Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Claiming desmopressin therapeutic equivalence in children requires pediatric data: a population PKPD analysis.

Michelet R, Dossche L, Van Herzeele C, Van Bocxlaer J, Vermeulen A, Vande Walle J; SAFE-PEDRUG consortium.

Eur J Clin Pharmacol. 2018 Mar;74(3):297-305. doi: 10.1007/s00228-017-2386-0. Epub 2017 Dec 3.

PMID:
29198064
2.

Recent advances in managing and understanding enuresis.

Van Herzeele C, Walle JV, Dhondt K, Juul KV.

F1000Res. 2017 Oct 24;6:1881. doi: 10.12688/f1000research.11303.1. eCollection 2017. Review.

3.

Enuresis: practical guidelines for primary care.

Vande Walle J, Rittig S, Tekgül S, Austin P, Yang SS, Lopez PJ, Van Herzeele C.

Br J Gen Pract. 2017 Jul;67(660):328-329. doi: 10.3399/bjgp17X691337. Epub 2017 May 22. No abstract available.

4.

The pathophysiology of monosymptomatic nocturnal enuresis with special emphasis on the circadian rhythm of renal physiology.

Dossche L, Walle JV, Van Herzeele C.

Eur J Pediatr. 2016 Jun;175(6):747-54. doi: 10.1007/s00431-016-2729-3. Epub 2016 May 2. Review.

PMID:
27138767
5.

Optimizing response to desmopressin in patients with monosymptomatic nocturnal enuresis.

Kamperis K, Van Herzeele C, Rittig S, Vande Walle J.

Pediatr Nephrol. 2017 Feb;32(2):217-226. doi: 10.1007/s00467-016-3376-7. Epub 2016 Apr 12. Review.

6.

Desmopressin (melt) therapy in children with monosymptomatic nocturnal enuresis and nocturnal polyuria results in improved neuropsychological functioning and sleep.

Van Herzeele C, Dhondt K, Roels SP, Raes A, Hoebeke P, Groen LA, Vande Walle J.

Pediatr Nephrol. 2016 Sep;31(9):1477-84. doi: 10.1007/s00467-016-3351-3. Epub 2016 Apr 11.

PMID:
27067081
7.

Incontinence and psychological problems in children: a common central nervous pathway?

Van Herzeele C, Vande Walle J.

Pediatr Nephrol. 2016 May;31(5):689-92. doi: 10.1007/s00467-016-3336-2. Epub 2016 Feb 12.

PMID:
26872485
8.

Neuropsychological functioning related to specific characteristics of nocturnal enuresis.

Van Herzeele C, Dhondt K, Roels SP, Raes A, Groen LA, Hoebeke P, Walle JV.

J Pediatr Urol. 2015 Aug;11(4):208.e1-6. doi: 10.1016/j.jpurol.2015.04.033. Epub 2015 Jun 27.

PMID:
26206411
9.

Challenging factors for enuresis treatment: Psychological problems and non-adherence.

Van Herzeele C, De Bruyne P, De Bruyne E, Walle JV.

J Pediatr Urol. 2015 Dec;11(6):308-13. doi: 10.1016/j.jpurol.2015.04.035. Epub 2015 Jun 24. Review.

PMID:
26182849
10.

Predictive parameters of response to desmopressin in primary nocturnal enuresis.

Van Herzeele C, Evans J, Eggert P, Lottmann H, Norgaard JP, Vande Walle J.

J Pediatr Urol. 2015 Aug;11(4):200.e1-8. doi: 10.1016/j.jpurol.2015.03.007. Epub 2015 May 21.

PMID:
26059526
11.

Sleep fragmentation and periodic limb movements in children with monosymptomatic nocturnal enuresis and polyuria.

Dhondt K, Van Herzeele C, Roels SP, Raes A, Groen LA, Hoebeke P, Walle JV.

Pediatr Nephrol. 2015 Jul;30(7):1157-62. doi: 10.1007/s00467-015-3044-3. Epub 2015 Feb 11.

PMID:
25669760
12.

Periodic limb movements during sleep are associated with a lower quality of life in children with monosymptomatic nocturnal enuresis.

Van Herzeele C, Dhondt K, Roels SP, Raes A, Groen LA, Hoebeke P, Vande Walle J.

Eur J Pediatr. 2015 Jul;174(7):897-902. doi: 10.1007/s00431-014-2474-4. Epub 2015 Jan 9.

PMID:
25567793
13.

Safety profile of desmopressin tablet for enuresis in a prospective study.

Van Herzeele C, De Bruyne P, Evans J, Eggert P, Lottmann H, Norgaard JP, Vande Walle J.

Adv Ther. 2014 Dec;31(12):1306-16. doi: 10.1007/s12325-014-0173-1. Epub 2014 Dec 12.

PMID:
25504157
14.

Sleep fragmentation and increased periodic limb movements are more common in children with nocturnal enuresis.

Dhondt K, Baert E, Van Herzeele C, Raes A, Groen LA, Hoebeke P, Vande Walle J.

Acta Paediatr. 2014 Jun;103(6):e268-72. doi: 10.1111/apa.12610. Epub 2014 Mar 17.

PMID:
24612370
15.

Pharmacokinetics of desmopressin administered as tablet and oral lyophilisate formulation in children with monosymptomatic nocturnal enuresis.

De Bruyne P, De Guchtenaere A, Van Herzeele C, Raes A, Dehoorne J, Hoebeke P, Van Laecke E, Vande Walle J.

Eur J Pediatr. 2014 Feb;173(2):223-8. doi: 10.1007/s00431-013-2108-2. Epub 2013 Aug 30.

PMID:
23989967
16.

Desmopressin melt improves response and compliance compared with tablet in treatment of primary monosymptomatic nocturnal enuresis.

Juul KV, Van Herzeele C, De Bruyne P, Goble S, Walle JV, Nørgaard JP.

Eur J Pediatr. 2013 Sep;172(9):1235-42. doi: 10.1007/s00431-013-1992-9. Epub 2013 May 16.

17.

Oral lyophylizate formulation of desmopressin: superior pharmacodynamics compared to tablet due to low food interaction.

De Guchtenaere A, Van Herzeele C, Raes A, Dehoorne J, Hoebeke P, Van Laecke E, Vande Walle J.

J Urol. 2011 Jun;185(6):2308-13. doi: 10.1016/j.juro.2011.02.039. Epub 2011 Apr 21.

PMID:
21511277
18.

Is there still a role for desmopressin in children with primary monosymptomatic nocturnal enuresis?: a focus on safety issues.

Van de Walle J, Van Herzeele C, Raes A.

Drug Saf. 2010 Apr 1;33(4):261-71. doi: 10.2165/11319110-000000000-00000.

PMID:
20297859
19.

Poor compliance with primary nocturnal enuresis therapy may contribute to insufficient desmopressin response.

Van Herzeele C, Alova I, Evans J, Eggert P, Lottmann H, Nørgaard JP, Vande Walle J.

J Urol. 2009 Oct;182(4 Suppl):2045-9. doi: 10.1016/j.juro.2009.06.001. Epub 2009 Aug 20.

PMID:
19695639
20.

Abnormal sleep architecture and refractory nocturnal enuresis.

Dhondt K, Raes A, Hoebeke P, Van Laecke E, Van Herzeele C, Vande Walle J.

J Urol. 2009 Oct;182(4 Suppl):1961-5. doi: 10.1016/j.juro.2009.05.103. Epub 2009 Aug 20.

PMID:
19695632

Supplemental Content

Loading ...
Support Center